Elahere 100 MG per 20 ML Injection

RxCUI: 2621559
RxNorm name: Elahere 100 MG per 20 ML Injection
Display name: Elahere 100 MG per 20 ML Injection
Full name: Elahere 100 MG per 20 ML Injection
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:38:45

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761310	Elahere	mirvetuximab soravtansine-gynx	351(a)	Rx	2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ELAHERE	MIRVETUXIMAB SORAVTANSINE	ImmunoGen, Inc.	00c424b5-6ccd-48ab-9e88-1986451120e2	2025-07-14	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2621559

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
00c424b5-6ccd-48ab-9e88-1986451120e2	Elahere 100 MG per 20 ML Injection	SY	14	These highlights do not include all the information needed to use ELAHERE safely and effectively. See full prescribing information for ELAHERE. ELAHERE ® (mirvetuximab soravtansine-gynx) injection, for intravenous use . Initial U.S. Approval: 2022	20250714
00c424b5-6ccd-48ab-9e88-1986451120e2	20 ML mirvetuximab soravtansine-gynx 5 MG/ML Injection [Elahere]	SBD	14	These highlights do not include all the information needed to use ELAHERE safely and effectively. See full prescribing information for ELAHERE. ELAHERE ® (mirvetuximab soravtansine-gynx) injection, for intravenous use . Initial U.S. Approval: 2022	20250714
00c424b5-6ccd-48ab-9e88-1986451120e2	Elahere 5 MG/ML per 20 ML Injection	SY	14	These highlights do not include all the information needed to use ELAHERE safely and effectively. See full prescribing information for ELAHERE. ELAHERE ® (mirvetuximab soravtansine-gynx) injection, for intravenous use . Initial U.S. Approval: 2022	20250714
00c424b5-6ccd-48ab-9e88-1986451120e2	ELAHERE 100 MG in 20 ML Injection	PSN	14	These highlights do not include all the information needed to use ELAHERE safely and effectively. See full prescribing information for ELAHERE. ELAHERE ® (mirvetuximab soravtansine-gynx) injection, for intravenous use . Initial U.S. Approval: 2022	20250714